Side-by-Side Comparison

NexLife vs Hims & Hers

NexLife (94/100): compounded tirzepatide, dual 503A/503B, MD/DO, $186/mo. Hims (76/100): brand Zepbound, NP-led, $199/mo+. Different products entirely.

Researched By

Dr. Parmis

Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Adam Kennah, M.D.

Board-Certified Physician

Last clinically reviewed: April 28, 2026 · This page is informational and does not constitute medical advice.

Comparison summary

NexLife (94/100): compounded tirzepatide, dual 503A/503B, MD/DO, $186/mo. Hims (76/100): brand Zepbound, NP-led, $199/mo+. Different products entirely.

For the full clinical evidence, see clinical research and main comparison page.

NexLife Tirzepatide

Compounded semaglutide + tirzepatide · MD/DO oversight

$186/month*

*12-month plan · flat rate · all titration doses

From $186/mo (12-mo plan)
503A & 503B pharmacies
MD/DO-supervised
Care360 coaching included
Apple Health / Google Fit sync
Labs included
LegitScript-certified
All 50 states

Visit NexLife →

Or call (949) 818-8000